(56 days)
Disposable neutral electrodes are self-adhesive, ready-to-use and single-use products and are an accessory for HF surgery in monopolar applications. The electrical circuit between the patient and the HF generator on the passive side.
BOWA Neutral Electrodes for adults, children and neonates provide a safe return path for electrosurgical current. The electrode consists of a conductive adhesive area surrounded by a non-conductive border adhesive. The conductive area is split in longitudinal or circumferential direction which enables a quicker detection of disconnection. The electrode backing is fluid resistant. The neutral electrode is single-use only, disposable, and non-sterile. The electrodes are supplied with or without a pre-attached cable. For the non-pre-corded electrodes, a reusable cable is available as accessory.
The provided document describes the FDA 510(k) premarket notification for BOWA Neutral Electrodes, which are accessories for electrosurgical cutting and coagulation devices. The document focuses on demonstrating substantial equivalence to predicate devices rather than proving a device meets specific performance criteria for AI-related functions.
Therefore, the information required to answer the prompt regarding acceptance criteria and a study proving a device meets acceptance criteria using an AI/ML context (e.g., accuracy, sensitivity, specificity) is not present in this document.
This document is for an electrosurgical accessory and its 510(k) submission primarily relies on:
- Comparison to predicate devices: Highlighting similarities in intended use, indications for use, principles of operation, and technological characteristics.
- Non-clinical performance data: This includes compliance with established electrical safety and biocompatibility standards (e.g., IEC 60601-2-2, ISO 10993-1, ISO 10993-5, ISO 10993-10), shelf-life testing, and reprocessing testing for consumable accessories.
There is no mention of AI/ML components, diagnostic performance metrics (accuracy, sensitivity, specificity), test sets, training sets, ground truth establishment by experts, or MRMC studies.
In summary, this document does not contain the information needed to address the prompt's specific requirements concerning acceptance criteria and study details for an AI-powered device.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo features the letters 'FDA' in a blue square, followed by the words 'U.S. FOOD & DRUG ADMINISTRATION' in blue text.
February 15, 2018
BOWA-electronics GmbH & Co. KG % Roxana Cernescu Senior Consultant QA/RA EMERGO Global Consulting, LLC 2500 Bee Cave Road Building 1, Suite 300 Austin, Texas 78746
Re: K173877
Trade/Device Name: BOWA Neutral Electrodes Regulation Number: 21 CFR 878.4400 Regulation Name: Electrosurgical Cutting and Coagulation Device and Accessories Regulatory Class: Class II Product Code: GEI Dated: December 21, 2017 Received: December 21, 2017
Dear Roxana Cernescu:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal
{1}------------------------------------------------
statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Jennifer R. Stevenson -S For Binita S. Ashar, M.D., M.B.A., F.A.C.S. Director Division of Surgical Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known) K173877
Device Name BOWA Neutral Electrodes
Indications for Use (Describe)
Disposable neutral electrodes are self-adhesive, ready-to-use and single-use products and are an accessory for HF surgery in monopolar applications. The electrical circuit between the patient and the HF generator on the passive side.
Type of Use (Select one or both, as applicable)X Prescription Use (Part 21 CFR 801 Subpart D)
| Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
510(k) Summary
DEVICE NAME
K__173877_
1. Submission Sponsor
BOWA-electronic GmbH & Co. KG
Heinrich-Hertz-Strasse 4 - 10
Gomaringen
72810
GERMANY
Contact: Wolf-Ruediger FRITZ
Title: Head of Quality Management / Regulatory Affairs Director
2. Submission Correspondent
Emergo Global Consulting, LLC
2500 Bee Cave Road
Building 1, Suite 300
Austin, TX 78746
Office Phone: (512) 327.9997
Contact: Roxana CERNESCU
Title: Senior Consultant, Regulatory
3. Date Prepared
2018-01-22
4. Device Identification
| Trade Name: | BOWA Neutral Electrodes |
|---|---|
| Common Name: | Neutral Electrodes |
| Classification Name: | Electrosurgical cutting and coagulation device and accessories |
{4}------------------------------------------------
| Regulation Number: | 21 CFR 878.4400 |
|---|---|
| Product Code: | GEI |
| Device Class: | Class II |
| Classification Panel: | General & Plastic Surgery |
5. Legally Marketed Predicate Device(s)
| Manufacturer | Leonhard Lang GmbH | Leonhard Lang GmbH |
|---|---|---|
| Trade Name | Skintact® Cool ContactElectrosurgical GroundingPlates with NH 04 Gel | Skintact® Neutral Electrodes forNeonates |
| 510(k) Number | K063161Primary predicate | K140500Secondary predicate |
6. Indication for Use Statement
Disposable neutral electrodes are self-adhesive, ready-to-use and single-use products and are an accessory for HF surgery in monopolar applications. The electrodes complete the electrical circuit between the patient and the HF generator on the passive side.
7. Device Description
BOWA Neutral Electrodes for adults, children and neonates provide a safe return path for electrosurgical current. The electrode consists of a conductive adhesive area surrounded by a non-conductive border adhesive. The conductive area is split in longitudinal or circumferential direction which enables a quicker detection of disconnection. The electrode backing is fluid resistant. The neutral electrode is single-use only, disposable, and non-sterile. The electrodes are supplied with or without a pre-attached cable. For the non-pre-corded electrodes, a reusable cable is available as accessory.
8. Substantial Equivalence Discussion
The following table compares the BOWA Neutral Electrodes to the predicate devices with respect to intended use, indications for use, principles of operation, technological characteristics, and performance testing. The comparison of the devices provides more detailed information regarding the basis for the determination of substantial equivalence. The subject device does not raise any new issues of safety or effectiveness based on the similarities to the predicate devices.
{5}------------------------------------------------
| Manufacturer | BOWA-electronicsGmbH & Co. KG | Leonhard LangGmbH | Leonhard LangGmbH | Device Comparison |
|---|---|---|---|---|
| Trade Name | BOWA NeutralElectrodes | Skintact® CoolContactElectrosurgicalGrounding Plateswith NH 04 Gel | Skintact® NeutralElectrodes forNeonates | |
| 510(k)Number | K173877 | K063161 | K140500 | N/A |
| Product Code | GEI | GEI | GEI | Same |
| RegulationNumber | 21 CFR 878.4400 | 21 CFR 878.4400 | 21 CFR 878.4400 | Same |
| RegulationName | Electrosurgicalcutting andcoagulation deviceand accessories | Electrosurgicalcutting andcoagulation deviceand accessories | Electrosurgicalcutting andcoagulation deviceand accessories | Same |
| Indications forUse | Disposable neutralelectrodes are self-adhesive, ready-to-use and single-useproducts and arean accessory for HFsurgery inmonopolarapplications. Theelectrodescomplete theelectrical circuitbetween thepatient and the HFgenerator on thepassive side. | Skintact Cool ContactElectrosurgicalGrounding Plates aredesigned for usewith electrosurgicalgenerators forcutting andcoagulation ofhuman tissue. | Skintact NeutralElectrodes forNeonates aredesigned for usewith electrosurgicalgenerators forcutting andcoagulation ofhuman tissue ofnewborn orprematurely bornpatients of betweenapproximately 1 and11 lbs (0.45 kg and4.99 kg) | Wording isdifferent, but theIntended Use is thesame, referenceSection 12, 12.2.1. |
| Prescription orОТС | Prescription | Prescription | Prescription | Same |
| Manufacturer | BOWA-electronicsGmbH & Co. KG | Leonhard LangGmbH | Leonhard LangGmbH | Device Comparison |
| Trade Name | BOWA NeutralElectrodes | Skintact® CoolContactElectrosurgicalGrounding Plateswith NH 04 Gel | Skintact® NeutralElectrodes forNeonates | |
| Mechanism ofAction | Neutral electrodesserve to return thecurrent from thepatient to theelectrosurgical unit(ESU) during HF-surgery inmonopolarapplication. | Neutral electrodesserve to return thecurrent from thepatient to theelectrosurgical unit(ESU) during HF-surgery inmonopolarapplication. | Neutral electrodesserve to return thecurrent from thepatient to theelectrosurgical unit(ESU) during HF-surgery inmonopolarapplication. | Same |
| TechnologyOverview | Multi-layer deviceconsisting of:Backing materialConductive layerConductiveadhesive hydrogelCover material | Multi-layer device,details of the layersare not known | Multi-layer device,details of the layersare not known | Similar |
| Population | Neonates, Children,Adults | Children and Adults | Neonates | The combination ofChildren, Adultsand Neonates leadsto the Samepopulation |
| AnatomicalLocation | Muscular or wellvascularizedconvex skin site, asclose as possible tothe operating field | Muscular or wellvascularized convexskin site, as close aspossible to theoperating field | Muscular or wellvascularized convexskin site, as close aspossible to theoperating field | Same |
| Weight rangeaccording toIEC 60601-2-2 | >15kg (33lbs)Adults>5kg (11lbs)Children and AdultsBetween 5 and15kg (11 to 33lbs)Children | >15kg (33lbs)>5kg (11lbs)Between 5 and 15kg(11 to 33lbs) | SameSameSame | |
| Manufacturer | BOWA-electronicsGmbH & Co. KG | Leonhard LangGmbH | Leonhard LangGmbH | Device Comparison |
| Trade Name | BOWA NeutralElectrodes | Skintact® CoolContactElectrosurgicalGrounding Plateswith NH 04 Gel | Skintact® NeutralElectrodes forNeonates | |
| <5kg (11lbs)Neonates | Between 0.45 and4.99kg (1lbs to 11lbs) | Same | ||
| Conductivearea | 140 cm² Adults110 cm² Childrenand Adults70 cm² Children40 cm² Neonates | 118 cm²107 cm²66 cm² | 34 cm² | Similar |
| Power | 140 cm² not limited110 cm² not limited70 cm² limited to200W40 cm² limited to100W | 118 cm² not limited107 cm² not limited66 cm² limited to120W | 34 cm² maximumWatt must bedetermined formode of operation | Similar |
| Material | Conductivelaminate:Al-foil / PET andmedical gradehydrogelBacking: PE-foamCover: release liner | Conductive laminate:Al-foil / PET andmedical gradehydrogelBacking: PE-foamCover: release liner | Not exactly known | Same |
| Self-adhesive | Yes | Yes | Yes | Same |
| Sterile | Non-sterile | Non-sterile | Non-sterile | Same |
| Single-Use /disposable | Yes | Yes | Yes | Same |
| Shelf Life | 36 months | 24 months | 24 months | Similar |
| Complies withISO 10993-1: | Yes | Yes | Yes | Same |
| Manufacturer | BOWA-electronicsGmbH & Co. KG | Leonhard LangGmbH | Leonhard LangGmbH | Device Comparison |
| Trade Name | BOWA NeutralElectrodes | Skintact® CoolContactElectrosurgicalGrounding Plateswith NH 04 Gel | Skintact® NeutralElectrodes forNeonates | |
| 10993-5 and10993-10 | ||||
| Complies withrelevantclauses of IEC60601-2-2 | Yes | Yes | Yes | Same |
| ElectricalSafety TestingPassed | Yes | Yes | Yes | Same |
| Compatibilitywith HFGenerators(ESU) | Yes, if ESU isequipped with aCQM System whichfulfils IEC 60601-1 | Yes, if ESU isequipped with aCQM System whichfulfils IEC 60601-1 | Yes, if ESU isequipped with aCQM System whichfulfils IEC 60601-1 | Same |
| Packaging | Sealed pouch | Sealed pouch | Sealed pouch | Same |
| Accessory | For electrodesprovided withoutcable,reusable cableavailable | For electrodesprovided withoutcable,reusable cableavailable | For electrodesprovided withoutcable,reusable cableavailable | Same |
Table 5A – Comparison of Characteristics
{6}------------------------------------------------
{7}------------------------------------------------
{8}------------------------------------------------
9. Non-Clinical Performance Data
As part of demonstrating safety and effectiveness of BOWA Neutral Electrodes and in showing substantial equivalence to the predicate devices, BOWA completed a number of non-clinical performance tests. The BOWA Neutral Electrodes meet all the requirements for overall design, biocompatibility, electrical safety, and reprocessing, as applicable, with results confirming that the design output meets the design inputs and specifications for the devices.
The BOWA Neutral Electrodes passed all the testing in accordance with internal requirements, and international standards shown below to support substantial equivalence of the predicate devices:
{9}------------------------------------------------
- . The device passed performance testing conducted according to standard IEC 60601-2-2:2009 "Medical electrical equipment - Part 2-2: Particular requirements for the basic safety and essential performance of high frequency surgical equipment and high frequency surgical accessories" and IEC 60601-1, relevant requirements. The testing conducted included: Contact impedance for new and aged devices, Resistance, Shelf-life, Isolation of active accessory, Patient lead.
- . Biocompatibility testing per ISO 10993-1 confirmed that the finished devices are biocompatible, and do not induce new risks. The following testing per ISO 10993-5 Cytotoxicity, and ISO 10993-10 (Skin Irritation and Sensitization) shown no adverse results.
- . Shelf Life Testing – According to real time aging of the BOWA Neutral Electrodes and subsequent electrical safety testing it could be proven that the BOWA Neutral Electrodes can be labeled with a shelf-life of 36 (thirty-six) months.
- . Reprocessing Testing – The BOWA Neutral Electrodes Cable reusable was subject to extensive reprocessing procedures simulating recommended procedures, as manual cleaning and disinfection, automated cleaning and disinfection as well as steam sterilization. Subsequently the main components of the cable were subject to electrical safety testing which proved that all requirements could be fulfilled.
10. Clinical Performance Data
No human clinical testing is required to support the medical device as the intended use is equivalent to the predicate devices. The non-clinical testing detailed in this submission supports the substantial equivalence of the device.
11. Statement of Substantial Equivalence
By definition, a device is substantially equivalent to a predicate device when the device has the same intended use and the same technological characteristics as the previously cleared predicate device. Or the device has the same intended use and different technological characteristics that can be demonstrated that the device is substantially equivalent to the predicate device, and that the new device does not raise additional questions regarding its safety and effectiveness as compared to the predicate device(s).
The BOWA Neutral Electrodes, as designed and manufactured, are determined to be substantially equivalent to the referenced predicate devices.
§ 878.4400 Electrosurgical cutting and coagulation device and accessories.
(a)
Identification. An electrosurgical cutting and coagulation device and accessories is a device intended to remove tissue and control bleeding by use of high-frequency electrical current.(b)
Classification. Class II.